Bayforest Capital »

Miragen Therapeutics shares owned by Bayforest Capital

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Bayforest Capital from 13F filings

Historical chart of Bayforest Capital investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Bayforest Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Bayforest Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $363k 20k 18.37

More positions owned by Bayforest Capital

Slide Ins Hldgs (SLDE)
Alexandria Real Estate Equities (ARE)
Perimeter Solutions Common Stock (PRM)
NetApp (NTAP)
Talos Energy (TALO)
Asbury Automotive (ABG)
C3 Ai Cl A (AI)
Solaredge Technologies (SEDG)
Hinge Health Cl A (HNGE)
Millrose Pptys Com Cl A (MRP)
Chord Energy Corporation Com New (CHRD)
A Mark Precious Metals (GOLD)
Bandwidth Com Cl A (BAND)
Perrigo SHS (PRGO)
Northern Oil And Gas Inc Mn (NOG)

View all positions for Bayforest Capital

Top funds holding Miragen Therapeutics

FMR
BlackRock
Bellevue Group
Paradigm Biocapital Advisors
Kynam Capital Management
Fairmount Funds Management
State Street Corporation
Vanguard Capital Management
Deep Track Capital
VR Adviser
T. Rowe Price Associates
Wellington Management Company
Vanguard Portfolio Management
Geode Capital Management
venBio Select Advisor

View all funds holding Miragen Therapeutics